Search result for Therapeutic
Amgen intends to issue a massive bond to help finance the $28 billion Horizon Therapeutics acquisition.
According to the company and deal documents, Amgen Inc. started talks with investors on Tuesday about a possible jumbo bond deal to help finance its $28 billion acquisition of Dublin-based Horizon Therapeutics.
In December, Amgen AMGN, +2.69% and Horizon HZNP, +0.28% announced plans for...
Global Cystic Fibrosis Therapeutics Market was Worth US$ 9.5 Bn in 2021, Projected to Reach CAGR of 16.9% over the Forecast Period
An inherited illness called cystic fibrosis causes the lungs and digestive tract to become clogged with thick, sticky mucus. From an early age, it can lead to breathing and gastrointestinal issues. The lungs sustain progressive damage over many years and may eventually stop functioning properly. ...
Global Plasma Protein Therapeutics Market was Worth US$ 24.38 Bn in 2021, growing at an estimated CAGR of 7.6% over the forecast period
Every day we come to know about a new disease, whether it be an acute or serious life-threatening disease. Over 200+ life-threatening diseases are affecting our immune or neurological systems such as multifocal motor neuropathy (MMN), chronic inflammatory demyelinating polyneuropathy (CIPD), idio...
Global Live Biotherapeutic Products and Microbiome Contract Manufacturing Market by Product, Type of Fermentation, Dosage Forms, Clinical Phases, Disease Indication, Services, End User and Region
The amount of development witnessed by medical science in the time span of previous several years is tremendous. Necessity is mother of invention and this is the primary reason, why evolution of new drugs and therapies remains dynamic. Owing to their effectiveness, the drugs or medicines made fro...
Global Immunodeficiency Therapeutics Market by Therapy Type, Route of Administration, Disorder Type, Demography, Test Type, End Users Region
Global immunodeficiency therapeutics market is among several growing markets today and there are many factors that impact it. There are numerous people, who are suffering from immunity disorders and this is majorly because of couple of reasons. These reasons are unhealthy or sedentary lifestyle, ...
Global RNA Based Therapeutics Market was Valued at US$ 4721.82 Mn in 2020 Growing at a CAGR of 16.87% over the forecast period
Antisense Oligonucleotides (ASO’s) to Hold Largest Market Share in 2020
According to the Absolute Markets Insights report, antisense oligonucleotides accounted for the largest market share in 2020. Antisense oligonucleotides have gained a significant importance s...
Global Natural Killer Cells Therapeutics Market to Grow at 17% during 2021 - 2029
According to Absolute Markets Insights report, antibody directed NK cell therapies is projected to witness fastest growth over the forecast period (2021-2029) in the natural killer cells therapeutics market. The growth in the antibody directed NK cell therapies segment can be attributed to increa...
Narcolepsy Therapeutics Market was Valued at US$ 6047.3 Mn in 2020
Absolute Markets Insights (AMI) reports a robust forecast for the narcolepsy therapeutics market during the 2021-2029 period. In its newly released report, AMI anticipates the market will grow owing to rapid change in lifestyle, especially in urban areas, which is leading to an increase in cases ...
Global Natural Killer Cells Therapeutics Market to Grow at 17% CAGR during 2021-2029
Natural killer (NK) cells, also known as large granular lymphocytes (LGL), are defined as a type of cytotoxic lymphocyte which is critical to the innate immune system in the human body. NK cells belong to the innate lymphoid cells (ILC) which is a rapidly expanding family in the world of biologic...
Global Pet Cancer Therapeutics Market to Grow at CAGR 9.3% by 2029
According to the American Veterinary Medical Association (AVMA), nearly 1 in 4 dogs develop neoplasia during their lifetime. AVMA also reports nearly half the dogs over the age of 10 develop cancer, mimicking their human brethren in high rates of cancer incidences. Furthermore, the rates of cance...
Brain Tumor Therapeutics Market was Valued at US$ 13,246.0 Mn in 2020 Owing to Rising Incidences of Cancer
Absolute Markets Insights (AMI) reports a robust forecast for the brain tumor therapeutics market during the 2021-2029 period. In its newly released report, AMI anticipates the market wil...
HRT THERAPY OF THERAPEUTICSMD AND THERAMEX GAIN UK AND BELGIUM APPROVAL
HIGHLIGHTS
- HRT Therapy of TherapeuticsMD and Theramex has gained approval in Belgium and UK.
- The new therapy called BIJUVA which is carried out through capsules called BIJUVE is the first and only oral therapy that combines HRT with bio-identical horm...
CIPLA THERAPEUTICS TO PARTNER WITH US-BASED SIGA TECHNOLOGIES TO DEVELOP NOVEL ANTIBIOTICS
Highlights
• Cipla Ltd said its US speciality business division has entered into agreement with US-based SIGA Technologies Inc to develop novel antibiotics
• Cipla Therapeutics has decided to partner with SIGA Technologies in order to develop novel antibiotics, speci...
Therapeutic Drug Monitoring Market is expected to grow at a CAGR of 6.27% over the Forecast Period, Owing to Technological Advancements which Improve Patient Outcomes and Reduce Treatment Costs
Technological advancements in healthcare sector have brought personalized medicine into practice. Therapeutic drug monitoring is form of personalized medicine technology which enables individualization of medicine dosage by analyzing and maintaining plasma or blood drug concentrations within a ta...
U.S. FIRM JOIN HANDS WITH AN ISRAELI FIRM TO START PRODUCTION OF 3D-PRINTED KIDNEYS
Highlights
• This partnership agreement brings together United Therapeutics' regenerative medicine and organ manufacturing capabilities and CollPlant's proprietary recombinant human collagen (rhCollagen) and BioInk technology
• The US-based firm has paid $3 m...
PRESIDENT TRUMP TO GIVE GOOD NEWS FOR CORONAVIRUS THERAPEUTICS WITHIN A COUPLE OF WEEKS
Highlights:
- President Trump has some good news to share in the coming two weeks about the therapeutics.
- President told reporters that he’s confident of disclosing some really good things about the therapeutics.
- He said that they have ...
VISTAGEN THERAPEUTICS AND EVERINSIGHT THERAPEUTICS ENTER STRATEGIC COLLABORATION
HIGHLIGHTS
- VistaGen Therapeutics Inc. and EverInsight Therapeutics Inc. have signed an agreement for a strategic collaboration.
- The target markets for both countries are China and South Korea.
- PH94B is very effective for the treatment of so...
JAPANESE CAPASULES CAN DELIVER CANCER THERAPEUTIC GENES
HIGHLIGHTS
- New capsules developed by Toshiba Corp. and Shinshu University can accurately deliver therapeutic genes into cancer cells.
- The successful demonstration of delivering genes is now the first of its kind in the whole world. Clinical trials to ...
US & ISRAEL DEVELOP TRAIL COVID-19 VACCINES: TO BE TESTED ON HUMANS
Highlights:
- Israel and the US develop trial vaccines
- Israel’s vaccine will be an oral vaccine
- USA is recruiting healthy people for vaccine trails
MIGAL Galilee Research Institute, Israel&nbs...
Summit Therapeutics plc: £7,330,811.40 in Stock
On January 14th, in a transaction on Tuesday, Summit Therapeutics PLC (LON:SUMM) insider Robert W. Duggan made a sale of 33,321,870 shares of the Summit Therapeutics stock. For a total transaction of £7,330,811.40 ($9,643,266.77), the sale was made at an average price of GBX 22 ($0.29).
...